$shom , BUSINESS SUMMARY
(SHOM – Southern Home Medical, Inc.) http://www.southernhomemedical.com/
Southern Home Medical, Inc. or SHOM is engaged in the healthcare services and medical equipment industry. The company plans to produce vital monitoring wearable systems enabling doctors to monitor patients while at home remotely. The monitoring systems can collect a wide range of health data from point of care, such as vital signs, weight, blood pressure, blood sugar, blood oxygen levels, heart rate, and electrocardiograms. The systems will allow for 24/7 information to improve the quality of care for patients.
Along with wearable medical technology, SHOM provides patients a summary of doctor’s notes with the ability to download and share notes with their primary care physician.
SHOM plans on streamlining the entire examination process allow their doctors to visit homes and offer referrals for tests, labs and x-rays in your area. Prescriptions can be ordered for patients during visit, if determined medically necessary.
SHOM doctors even make sure availability of medication at preferred pharmacy for pickup at your convenience. SHOM is also designed to handle non-emergent medical problems, specializing in Stem Cell Preventive Medicine. Stem cells are special cells that can grow into various other specialized sells. Mesenchymal stem cells are multi-potent stem cells that can differentiate into a variety of cell types including cartilage, bone, tendon, ligaments, fat, marrow, CNS, skin and muscles.
Stem cells also have what is called immune-privilege. That means that they will not be attacked by the host's immune system, unlike other types of foreign tissues. Stem cells are thus able to potentially treat many diseases that normally would not be feasible to treat with standard procedures.
MARKET OUTLOOK
The stem cell and regenerative market is leading advancements in an unprecedented way and markets are responding. The global stem cells market size was valued at USD 37.88 billion in 2013 and is expected to grow at a CAGR of over 20.0% up to 2020.
A more modest estimate, puts the global market for stem cells at roughly USD 26.6 billion by 2021, with a CAGR of 13.7% and estimate of USD 12 billion in 2016.
Rising R&D initiatives to develop therapeutic options for chronic diseases and growing demand as regenerative treatment option are the most significant drivers of this industry. High unmet medical needs have led to more government initiatives for drug development and discov
(SHOM – Southern Home Medical, Inc.) http://www.southernhomemedical.com/
Southern Home Medical, Inc. or SHOM is engaged in the healthcare services and medical equipment industry. The company plans to produce vital monitoring wearable systems enabling doctors to monitor patients while at home remotely. The monitoring systems can collect a wide range of health data from point of care, such as vital signs, weight, blood pressure, blood sugar, blood oxygen levels, heart rate, and electrocardiograms. The systems will allow for 24/7 information to improve the quality of care for patients.
Along with wearable medical technology, SHOM provides patients a summary of doctor’s notes with the ability to download and share notes with their primary care physician.
SHOM plans on streamlining the entire examination process allow their doctors to visit homes and offer referrals for tests, labs and x-rays in your area. Prescriptions can be ordered for patients during visit, if determined medically necessary.
SHOM doctors even make sure availability of medication at preferred pharmacy for pickup at your convenience. SHOM is also designed to handle non-emergent medical problems, specializing in Stem Cell Preventive Medicine. Stem cells are special cells that can grow into various other specialized sells. Mesenchymal stem cells are multi-potent stem cells that can differentiate into a variety of cell types including cartilage, bone, tendon, ligaments, fat, marrow, CNS, skin and muscles.
Stem cells also have what is called immune-privilege. That means that they will not be attacked by the host's immune system, unlike other types of foreign tissues. Stem cells are thus able to potentially treat many diseases that normally would not be feasible to treat with standard procedures.
MARKET OUTLOOK
The stem cell and regenerative market is leading advancements in an unprecedented way and markets are responding. The global stem cells market size was valued at USD 37.88 billion in 2013 and is expected to grow at a CAGR of over 20.0% up to 2020.
A more modest estimate, puts the global market for stem cells at roughly USD 26.6 billion by 2021, with a CAGR of 13.7% and estimate of USD 12 billion in 2016.
Rising R&D initiatives to develop therapeutic options for chronic diseases and growing demand as regenerative treatment option are the most significant drivers of this industry. High unmet medical needs have led to more government initiatives for drug development and discov
